The impact of testing and infection prevention and control strategies on within-hospital transmission dynamics of COVID-19 in English hospitals.


Journal

Philosophical transactions of the Royal Society of London. Series B, Biological sciences
ISSN: 1471-2970
Titre abrégé: Philos Trans R Soc Lond B Biol Sci
Pays: England
ID NLM: 7503623

Informations de publication

Date de publication:
19 07 2021
Historique:
entrez: 31 5 2021
pubmed: 1 6 2021
medline: 11 6 2021
Statut: ppublish

Résumé

Nosocomial transmission of SARS-CoV-2 is a key concern, and evaluating the effect of testing and infection prevention and control strategies is essential for guiding policy in this area. Using a within-hospital SEIR transition model of SARS-CoV-2 in a typical English hospital, we estimate that between 9 March 2020 and 17 July 2020 approximately 20% of infections in inpatients, and 73% of infections in healthcare workers (HCWs) were due to nosocomial transmission. Model results suggest that placing suspected COVID-19 patients in single rooms or bays has the potential to reduce hospital-acquired infections in patients by up to 35%. Periodic testing of HCWs has a smaller effect on the number of hospital-acquired COVID-19 cases in patients, but reduces infection in HCWs by as much as 37% and results in only a small proportion of staff absences (approx. 0.3% per day). This is considerably less than the 20-25% of staff that have been reported to be absent from work owing to suspected COVID-19 and self-isolation. Model-based evaluations of interventions, informed by data collected so far, can help to inform policy as the pandemic progresses and help prevent transmission in the vulnerable hospital population. This article is part of the theme issue 'Modelling that shaped the early COVID-19 pandemic response in the UK'.

Identifiants

pubmed: 34053255
doi: 10.1098/rstb.2020.0268
pmc: PMC8165586
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20200268

Subventions

Organisme : Versus Arthritis
ID : 22294
Pays : United Kingdom

Références

Lancet Infect Dis. 2020 Dec;20(12):1401-1408
pubmed: 32758438
Elife. 2020 Aug 21;9:
pubmed: 32820721
Emerg Infect Dis. 2015 Nov;21(11):2022-8
pubmed: 26488116
J R Soc Interface. 2010 Jun 6;7(47):873-85
pubmed: 19892718
Sex Health. 2005;2(4):255-8
pubmed: 16402675
PLoS Comput Biol. 2013;9(2):e1002916
pubmed: 23468606
JAMA Netw Open. 2020 May 1;3(5):e209673
pubmed: 32437576
Lancet Infect Dis. 2020 Nov;20(11):1273-1280
pubmed: 32622380
Lancet. 2020 May 2;395(10234):e77-e78
pubmed: 32333843
Br Med Bull. 2009;92:33-42
pubmed: 19855103
Lancet Respir Med. 2020 Sep;8(9):885-894
pubmed: 32717210
J Infect Dis. 2018 Sep 22;218(9):1485-1489
pubmed: 29873767
Elife. 2020 Jun 19;9:
pubmed: 32558644
Clin Infect Dis. 2021 Nov 2;73(9):e3127-e3129
pubmed: 33570097
Palliat Med. 2008 Sep;22(6):702-10
pubmed: 18715968
J Infect. 2021 Nov;83(5):565-572
pubmed: 34474055
Nat Rev Microbiol. 2008 Jun;6(6):477-87
pubmed: 18533288
Lancet. 2020 May 23;395(10237):1608-1610
pubmed: 32401714
Lancet Infect Dis. 2020 Dec;20(12):1381-1389
pubmed: 32822577
Lancet Infect Dis. 2020 Nov;20(11):1263-1272
pubmed: 32679081
Genome Biol. 2014 Nov 18;15(11):538
pubmed: 25418119
JAMA Intern Med. 2019 Nov 01;179(11):1501-1506
pubmed: 31424489
Infect Control Hosp Epidemiol. 2007 Apr;28(4):412-7
pubmed: 17385146
Infect Control Hosp Epidemiol. 2016 Jun;37(6):680-4
pubmed: 27074865

Auteurs

Stephanie Evans (S)

Modelling and Economics Unit, National Infection Service, Public Health England, London, UK.
Healthcare Associated Infection and Antimicrobial Resistance Division, National Infection Service, Public Health England, London, UK.

Emily Agnew (E)

Modelling and Economics Unit, National Infection Service, Public Health England, London, UK.
Healthcare Associated Infection and Antimicrobial Resistance Division, National Infection Service, Public Health England, London, UK.

Emilia Vynnycky (E)

Modelling and Economics Unit, National Infection Service, Public Health England, London, UK.
TB Modelling Group, TB Centre and Centre for Mathematical Modelling of Infectious Diseases, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.

James Stimson (J)

Modelling and Economics Unit, National Infection Service, Public Health England, London, UK.
Healthcare Associated Infection and Antimicrobial Resistance Division, National Infection Service, Public Health England, London, UK.

Alex Bhattacharya (A)

Healthcare Associated Infection and Antimicrobial Resistance Division, National Infection Service, Public Health England, London, UK.

Christopher Rooney (C)

Leeds Institute of Medical Research, University of Leeds, Leeds, UK.

Ben Warne (B)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Julie Robotham (J)

Modelling and Economics Unit, National Infection Service, Public Health England, London, UK.
Healthcare Associated Infection and Antimicrobial Resistance Division, National Infection Service, Public Health England, London, UK.
NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH